Drug discovery products

New therapeutic anti-infective products development based on ThyX inhibition.
These products can be considered as molecular intermediates in the drug discovery process. The products provided are high content hit towards enzymes with thymdylate synthase action or leads with optimal biological activity in cellular pharmacokinetic assays or pre-clinical drug candidates.

Basic research products

Specific enzyme substrates
(Beta-lactamase substrates, GARFT substrate, on request enzyme substrates and ligands substrates)

Featured libraries

Scaffold validation, chemistry and screening
Screening of request-based targets against Tydock Pharma proprietary compound library

Enzyme assays validation

Protein purification methodologies and preparation

Substrate chromatography affinity for enzyme purification
Technologies and methods

Lead generation platform

Target/pathway-oriented medicinal chemistry platform

Activity and early screening platform